FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1986020765> ?p ?o ?g. }

• W1986020765 endingPage "NA" @default.
• W1986020765 startingPage "NA" @default.
• W1986020765 abstract "Natural killer T (NKT) cells are potent modulators of antitumor immunity. Their protective effects can be achieved upon their activation by glycolipid ligands presented in the context of the CD1d molecule. These CD1d-binding glycolipid antigens have been described as potent therapeutic agents against tumors, infections, as well as autoimmune diseases. Immunoregulatory and therapeutic effects of glycolipid ligands depend on their structure and modes of administration. Therefore, more studies are needed for optimization of the particular therapeutic settings. This study was focused on the tumor-inhibitory effects of 12 carbon acyl chain β-galactosyl ceramide (C12 β-D-Galactosyl Ceramide; β-GalCer(C12)) on the growth of human papillomavirus type 16 (HPV16)-associated neoplasms transplanted in syngeneic mice. Treatment of tumor-bearing mice with β-GalCer(C12) 3–14 days after tumor cell transplantation significantly inhibited the growth of the major histocompatability complex (MHC) Class I-positive (TC-1), as well as MHC Class I-deficient (TC-1/A9) HPV16-asssociated tumors. Moreover, administration of β-GalCer(C12) after surgical removal of TC-1 tumors inhibited the growth of tumor recurrences. Similar results were obtained in the treatment of tumors after chemotherapy. β-GalCer(C12) treatment turned out to be also synergistic with immunotherapy based on administration of IL-12-producing cellular vaccines. These results suggest that β-GalCer(C12), whose antitumor effects have so far not been studied in detail, can be effective for the treatment of minimal residual tumor disease as well as an adjuvant for cancer immunotherapy." @default.
• W1986020765 created "2016-06-24" @default.
• W1986020765 creator A5010063233 @default.
• W1986020765 creator A5023684480 @default.
• W1986020765 creator A5048118680 @default.
• W1986020765 creator A5059223271 @default.
• W1986020765 creator A5061453657 @default.
• W1986020765 creator A5081464065 @default.
• W1986020765 date "2010-01-01" @default.
• W1986020765 modified "2023-10-14" @default.
• W1986020765 title "Therapy for minimal residual tumor disease: β-Galactosylceramide inhibits the growth of recurrent HPV16-associated neoplasms after surgery and chemotherapy" @default.
• W1986020765 cites W1483804182 @default.
• W1986020765 cites W1487118208 @default.
• W1986020765 cites W1595766784 @default.
• W1986020765 cites W1966906534 @default.
• W1986020765 cites W2019020516 @default.
• W1986020765 cites W2028452125 @default.
• W1986020765 cites W2039721715 @default.
• W1986020765 cites W2044197227 @default.
• W1986020765 cites W2063026834 @default.
• W1986020765 cites W2064858323 @default.
• W1986020765 cites W2085117860 @default.
• W1986020765 cites W2090777237 @default.
• W1986020765 cites W2093497258 @default.
• W1986020765 cites W2111506773 @default.
• W1986020765 cites W2119695630 @default.
• W1986020765 cites W2121477549 @default.
• W1986020765 cites W2136062652 @default.
• W1986020765 cites W2142194554 @default.
• W1986020765 cites W2150689181 @default.
• W1986020765 cites W2157230516 @default.
• W1986020765 cites W2158117877 @default.
• W1986020765 cites W2163270673 @default.
• W1986020765 doi "https://doi.org/10.1002/ijc.24887" @default.
• W1986020765 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19739073" @default.
• W1986020765 hasPublicationYear "2010" @default.
• W1986020765 type Work @default.
• W1986020765 sameAs 1986020765 @default.
• W1986020765 citedByCount "4" @default.
• W1986020765 countsByYear W19860207652018 @default.
• W1986020765 crossrefType "journal-article" @default.
• W1986020765 hasAuthorship W1986020765A5010063233 @default.
• W1986020765 hasAuthorship W1986020765A5023684480 @default.
• W1986020765 hasAuthorship W1986020765A5048118680 @default.
• W1986020765 hasAuthorship W1986020765A5059223271 @default.
• W1986020765 hasAuthorship W1986020765A5061453657 @default.
• W1986020765 hasAuthorship W1986020765A5081464065 @default.
• W1986020765 hasBestOaLocation W19860207651 @default.
• W1986020765 hasConcept C121608353 @default.
• W1986020765 hasConcept C126322002 @default.
• W1986020765 hasConcept C147483822 @default.
• W1986020765 hasConcept C170627219 @default.
• W1986020765 hasConcept C190283241 @default.
• W1986020765 hasConcept C19317047 @default.
• W1986020765 hasConcept C203014093 @default.
• W1986020765 hasConcept C207936829 @default.
• W1986020765 hasConcept C22222904 @default.
• W1986020765 hasConcept C2776090121 @default.
• W1986020765 hasConcept C2776694085 @default.
• W1986020765 hasConcept C2777701055 @default.
• W1986020765 hasConcept C2777851122 @default.
• W1986020765 hasConcept C2777863537 @default.
• W1986020765 hasConcept C2778607024 @default.
• W1986020765 hasConcept C502942594 @default.
• W1986020765 hasConcept C55493867 @default.
• W1986020765 hasConcept C71924100 @default.
• W1986020765 hasConcept C86803240 @default.
• W1986020765 hasConcept C8891405 @default.
• W1986020765 hasConceptScore W1986020765C121608353 @default.
• W1986020765 hasConceptScore W1986020765C126322002 @default.
• W1986020765 hasConceptScore W1986020765C147483822 @default.
• W1986020765 hasConceptScore W1986020765C170627219 @default.
• W1986020765 hasConceptScore W1986020765C190283241 @default.
• W1986020765 hasConceptScore W1986020765C19317047 @default.
• W1986020765 hasConceptScore W1986020765C203014093 @default.
• W1986020765 hasConceptScore W1986020765C207936829 @default.
• W1986020765 hasConceptScore W1986020765C22222904 @default.
• W1986020765 hasConceptScore W1986020765C2776090121 @default.
• W1986020765 hasConceptScore W1986020765C2776694085 @default.
• W1986020765 hasConceptScore W1986020765C2777701055 @default.
• W1986020765 hasConceptScore W1986020765C2777851122 @default.
• W1986020765 hasConceptScore W1986020765C2777863537 @default.
• W1986020765 hasConceptScore W1986020765C2778607024 @default.
• W1986020765 hasConceptScore W1986020765C502942594 @default.
• W1986020765 hasConceptScore W1986020765C55493867 @default.
• W1986020765 hasConceptScore W1986020765C71924100 @default.
• W1986020765 hasConceptScore W1986020765C86803240 @default.
• W1986020765 hasConceptScore W1986020765C8891405 @default.
• W1986020765 hasLocation W19860207651 @default.
• W1986020765 hasLocation W19860207652 @default.
• W1986020765 hasOpenAccess W1986020765 @default.
• W1986020765 hasPrimaryLocation W19860207651 @default.
• W1986020765 hasRelatedWork W1502561265 @default.
• W1986020765 hasRelatedWork W165674706 @default.
• W1986020765 hasRelatedWork W1974641004 @default.
• W1986020765 hasRelatedWork W1986020765 @default.
• W1986020765 hasRelatedWork W2046410511 @default.
• W1986020765 hasRelatedWork W2068633365 @default.

• next